Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Controlled release of dexamethasone from subcutaneously-implanted biosensors in pigs: localized anti-inflammatory benefit without systemic effects.

Ward WK, Hansen JC, Massoud RG, Engle JM, Takeno MM, Hauch KD.

J Biomed Mater Res A. 2010 Jul;94(1):280-7. doi: 10.1002/jbm.a.32651.

PMID:
20186727
2.

[Systemic side effects of topically applied corticosteroid medication (author's transl)].

Meredig WE, Jentzen F, Hartmann F.

Klin Monbl Augenheilkd. 1980 Jun;176(6):907-10. German.

PMID:
7453013
3.

Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.

Hori Y, Hu DE, Yasui K, Smither RL, Gresham GA, Fan TP.

Br J Pharmacol. 1996 Aug;118(7):1584-91.

4.

Effect of intra-articular versus systemic anti-inflammatory drugs in a rabbit model of temporomandibular joint inflammation.

Swift JQ, Roszkowski MT, Alton T, Hargreaves KM.

J Oral Maxillofac Surg. 1998 Nov;56(11):1288-95; discussion 1295-6.

PMID:
9820217
5.

Effects of dermal dexamethasone application on ACTH and both basal and ACTH-stimulated cortisol concentration in normal horses.

Abraham G, Allersmeier M, Gottschalk J, Schusser GF, Hoppen HO, Ungemach FR.

J Vet Pharmacol Ther. 2009 Aug;32(4):379-87. doi: 10.1111/j.1365-2885.2008.01054.x.

PMID:
19614843
6.
7.

The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.

Dorr RT, Alberts DS, Chen HS.

Cancer Chemother Pharmacol. 1980;5(1):17-20.

PMID:
7460191
8.
9.
10.

Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis.

Patil SD, Papadmitrakopoulos F, Burgess DJ.

J Control Release. 2007 Jan 22;117(1):68-79.

PMID:
17169457
12.
13.

Mast cells and tissue reaction to intraperitoneally implanted polymer capsules.

Christenson L, Wahlberg L, Aebischer P.

J Biomed Mater Res. 1991 Sep;25(9):1119-31.

PMID:
1778997
14.

Endocrine and immune effects of dexamethasone in unilateral total knee replacement.

Smith C, Erasmus PJ, Myburgh KH.

J Int Med Res. 2006 Nov-Dec;34(6):603-11.

PMID:
17294992
15.

Site-specific dexamethasone delivery for the prevention of neointimal thickening after vascular stent implantation.

Muller DW, Golomb G, Gordon D, Levy RJ.

Coron Artery Dis. 1994 May;5(5):435-42.

PMID:
7921375
16.

Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone.

Ferreira SH, Cunha FQ, Lorenzetti BB, Michelin MA, Perretti M, Flower RJ, Poole S.

Br J Pharmacol. 1997 Jul;121(5):883-8.

18.

Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)?

Ward WK, Quinn MJ, Wood MD, Tiekotter KL, Pidikiti S, Gallagher JA.

Biosens Bioelectron. 2003 Nov 30;19(3):155-63.

PMID:
14611750
19.
20.
Items per page

Supplemental Content

Support Center